CD45 is a receptor-like protein tyrosine phosphatase critically involv
ed in the regulation of initial effector functions in B- and T-cells.
The protein comprises two phosphatase (PTP) domains in its cytoplasmic
region. However, whether each PTP domain has enzyme activity by itsel
f or whether both domains are required to build up a functional enzyme
is unclear. We have studied different constructions of human CD45 com
prising the two PTP domains, both separately and as a single protein,
fused to maltose-binding protein (MBP). In apparent contrast with prev
ious studies, we show that the first PTP domain of CD45 (when fused to
MBP) may be a viable phosphatase in the absence of the second domain.
Phosphatase activity resides in the monomeric form of the protein and
is lost after proteolytic cleavage of the fusion partner, indicating
that MBP specifically activates the first PTP domain. Furthermore, cha
nges in the optimal pH for activity with respect to wild-type CD45 sug
gest that protein-protein interactions involving residues in the neigh
bourhood of the catalytic site mediate enzyme activation. (C) 1997 Fed
eration of European Biochemical Societies.